APA (7th ed.) Citation

E, G., SK, A., CR, M., JN, S., K, J., JC, B., . . . PY, W. (2018). Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: Results of Alliance N0874/ABTC 02. Neuro-oncology, 20(4), 546. https://doi.org/10.1093/neuonc/nox161

Chicago Style (17th ed.) Citation

E, Galanis, et al. "Phase I/II Trial of Vorinostat Combined with Temozolomide and Radiation Therapy for Newly Diagnosed Glioblastoma: Results of Alliance N0874/ABTC 02." Neuro-oncology 20, no. 4 (2018): 546. https://doi.org/10.1093/neuonc/nox161.

MLA (9th ed.) Citation

E, Galanis, et al. "Phase I/II Trial of Vorinostat Combined with Temozolomide and Radiation Therapy for Newly Diagnosed Glioblastoma: Results of Alliance N0874/ABTC 02." Neuro-oncology, vol. 20, no. 4, 2018, p. 546, https://doi.org/10.1093/neuonc/nox161.